Feb 12
TransCelerate Highlights Digital Momentum and Global Collaboration in 2025 Annual Report
02/18/2026
TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic approaches to clinical development.
Read the full article featuring Janice Chang from Applied Clinical Trials here.
Related Blog Posts
Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation
Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological advances to enable breakthroughs in processes as well as pipelines. Read the full article featuring Rob DiCicco from Citeline here.
How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together
When TransCelerate launched more than a decade ago, few expected a collaboration among direct competitors to last, let alone grow into a durable, trusted organization. The numbers were seemingly against us: Most consortia struggle to survive beyond two years, typically dissolving once their founding champions retire or member companies deprioritize their involvement. Read the full…
Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
Interest in digital approaches to clinical protocols has grown steadily as sponsors, solution providers, sites, and regulators explore ways to make study planning and execution more efficient. Read the full article featuring Rob DiCicco from Clinical Leader here.